Abstract

IMPLEMENTATION AND EVALUATION OF PHARMACEUTICAL CARE FOR ISCHEMIC HEART DISEASE PATIENTS IN A TERTIARY CARE TEACHING HOSPITAL

*Sajidul Hoque, Faseeh M. K., Nisar Ahmed, Mahendra Kumar B. J., Uthamanand C. and Shahid Ashraful Talukdar

ABSTRACT

Introduction: A study on Implementation and Evaluation of Pharmaceutical care for Ischemic heart disease patients in a tertiary care teaching hospital. Ischemic heart disease (IHD) refers to a group of disease which includes stable angina, unstable angina, myocardial infraction (MI) and sudden cardiac death. Coronary artery disease (CAD) or IHD is common in populations. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in adults worldwide. Pharmacist can also contribute positively to IHD management by providing PC programs, which involve working closely with the patient and other health care professionals in designing, implementing and monitoring therapeutic plans to achieve specific outcomes that will improve patient QOL. Aim: To assess the pharmaceutical care services in IHD patients. Methodology: This was a prospective cohort study conducted at the department of General Medicine, General Surgery and ICU at CSI Holdsworth Memorial (Mission) Hospital Mysore. Total number of 20 IHD patients was enrolled in this study. A well designed Data Collection Form, Patient Information Leaflets and Questionnaires were used for collecting the details of patients enrolled. The information was documented and subjected to suitable statistical methods. Result: The Mean ± Standard deviation for gender distribution in our study was found to be 7.071067812 respectively. The Mean ± Standard deviation for distribution based on wards in our study was found to be 1.870828693 respectively. The Mean ± Standard deviation for family history distribution in our study was found to be 12.72792206 respectively. The Mean ± Standard deviation for diet distribution in our study was found to be 11.3137085 respectively. The Mean ± Standard deviation for age distribution in our study was found to be 4.082482905 respectively. The Mean ± Standard deviation for average systolic and diastolic blood pressure distribution found in our study was 10.53549 and 4.596876203 respectively. The Mean ± Standard deviation for Haemoglobin level distribution was found to be 1.675243502 respectively. The Mean ± Standard deviation for average GRBS mg/dl distribution was found to be 32.82876456 respectively. The total number of drug interactions in each patient’s medications was entered to Microsoft excel sheet and graph was made. Each patient’s response was collected for baseline, first follow-up and second follow-up. The data was entered in Microsoft excel sheet and graphs were made for every questionnaires, it clearly shows the development of patients in each sitting. Conclusion: This study provides information that providing pharmaceutical care by pharmacist to IHD patients improve the QOL, KAP and adherence to medication. It also have an impact on controlling blood pressure in IHD patients.

Keywords: Clinical Pharmacist, Tertiary care, Teaching Hospital, PC, IHD, CSI-HMH, SBP, DBP, Prospective cohort study.